Hematopoietic stem cell transplant recipients
Monitoring of Cytomegalovirus Viral Loads by Two Molecular Assays in Whole Blood and Plasma Samples from Hematopoietic Stem Cell Transplant Recipients
... Previous studies have shown that CMV viral loads in whole blood tend to be higher than those in plasma, as whole blood contains free and cell-associated virions, while plasma contains only cell- free ...
6
Paradoxical Rising Cytomegalovirus Antigenemia during Preemptive Ganciclovir Therapy in Hematopoietic Stem Cell Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes
... allogeneic hematopoietic stem cell transplantation (HCT) (3, 17, ...HCT recipients (2), occasional cases show increasing CMV antigen- emia levels during preemptive GCV ...
6
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital
... Allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients are the primary constitutes of this high-risk ...allo-HSCT recipients have also been reported to have ...
10
DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation
... lung transplant and HSCT recipients [8, ...HSCT recipients (Table 1), Case 1 presented very early after transplant and failed to engraft despite growth factor stimulation which played a ...
5
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients
... Over the last 15 years at our center roughly 800 pediatric and 400 adult patients have received a hematopoietic stem cell transplant (HSCT). Recently, T-cell depletion has been ...
5
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
... Results: The primary outcome of this study was the one-year incidence for IFDs after HSCT, which was 10.3 % (25/242). Overall 28 patients experienced an IFD – 20 probable and 8 proven – with invasive aspergillosis being ...
9
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
... health. Hematopoietic stem cell transplant recipients undergo prolonged exposure to antimicrobials, chemo- therapeutic agents, and immunosuppressants, resulting in profound shifts in ...
6
Rhizomucor and Scedosporium Infection Post Hematopoietic Stem-Cell Transplant
... Hematopoietic stem-cell transplant recipients are at increased risk of developing invasive fungal ...allogeneic hematopoietic stem-cell transplant from an ...
7
Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
... and hematopoietic stem cell transplant recipients (22), this assay was found to be more sensitive that cell culture assays and to have a sensitivity and specificity similar to ...
7
Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study
... HSCT recipients having primary hematological disorders other than AML ie patients hav- ing disorders such as SAA, MDS, ALL developed ...in recipients of other forms of HSCT eg autologous grafts (21 ...
7
<p>Identification and Treatment of Tuberculosis in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Review of the Literature</p>
... of hematopoietic stem cell transplantation (HSCT) are at a high risk of being infected with opportunistic pathogens, among which Mycobacterium tuber- culosis (Mtb) is one of the most life-threatening ...
8
Pediatric unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and reduced intensity, TBI-free conditioning regimens in salvage transplantations
... developed skin aGvHD (maximal stage III), 2 of them acute gut GvHD (both stage III) and 1 liver aGvHD (stage II). In 2 recipients, cGvHD was observed (1 limited, 1 ex- tensive). All patients showed full donor ...
6
Marked stem cell factor expression in the airways of lung transplant recipients
... mobilise stem cells of hematopoietic origin [10,23], it could partic- ipate in their recruitment to the lung, in keeping with a recent experimental model of lung injury showing a par- tial pulmonary ...
8
Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients
... Patients received acyclovir or valacyclovir prophy- laxis for prevention of herpes simplex viruses and varicella-zoster virus; cord blood transplant recipients after June 2008 received high-dose ...
11
Cancer biotherapy resource
... In cellular therapy, processed tissue from animal embryos, fetus or organs are injected or taken orally. Tissues are obtained from specific organs in correspondence with the unhealthy organs or tissues of the recipient. ...
64
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients
... different transplant centers likely secondary to different immuno- suppressive regimens, allograft types and patient popula- tion ...lung transplant recipients ...etic stem cell ...
14
PCR in Diagnosis of Invasive Aspergillosis: a Meta Analysis of Diagnostic Performance
... sequential cell lysis methods could not improve PCR assay performance for patients with IA, in contrast to what would be expected for samples spiked with Aspergillus ...
12
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
... Although the efficacy of ribavirin for the treatment of LRTI is debatable, early treatment to prevent progression to pneumonia remains an unanswered question. In addition, the role of ribavirin to prevent long-term ...
7
Management of <em>Candida</em> infections in liver transplant recipients: current perspectives
... Model of End-Stage Liver Disease (MELD) score was first developed in 2000 to predict mortality of patients under- going transjugular intrahepatic portosystemic shunts and is now widely used to prioritize patients who ...
9
Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin’s lymphoma and multiple myeloma
... + cell yield may be useful for developing endpoints for clinical trials, cell yield is estimated retrospectively after leukapheresis and does not permit early intervention strategies with the advent of new ...
12